IA
VKTX icon

IFP Advisors’s Viking Therapeutics VKTX Stock Holding History

IFP Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
61,616
+1,043
+2% +$33.7K 0.04% 431
2026
Q1 		$1.97M Sell
60,573
-1,105
-2% -$35.5K 0.04% 456
2025
Q4 		$2.17M Buy
61,678
+1,023
+2% +$36.2K 0.05% 395
2025
Q3 		$1.59M Buy
60,655
+8,730
+17% +$260K 0.04% 435
2025
Q2 		$1.48M Buy
51,925
+10,048
+24% +$265K 0.04% 447
2025
Q1 		$1.01M Sell
41,877
-247
-0.6% -$7.81K 0.03% 547
2024
Q4 		$1.7M Buy
42,124
+21,825
+108% +$1.24M 0.06% 370
2024
Q3 		$1.29M Buy
20,299
+19,769
+3,730% +$1.16M 0.05% 413
2024
Q2 		$28.1K Buy
+530
New +$34.7K ﹤0.01% 1921
2022
Q4 		– Sell
-416
Closed -$4K – 4859
2022
Q3 		$4K Hold
416
– – ﹤0.01% 4159
2022
Q2 		$4K Hold
416
– – ﹤0.01% 3922
2022
Q1 		$4K Buy
416
+400
+2,500% +$1.44K ﹤0.01% 3921
2021
Q4 		$1K Sell
16
-2,888
-99% -$16.2K ﹤0.01% 3138
2021
Q3 		$32K Buy
2,904
+30
+1% +$185 ﹤0.01% 1779
2021
Q2 		$15K Sell
2,874
-18
-0.6% -$107 ﹤0.01% 2065
2021
Q1 		$16K Buy
2,892
+381
+15% +$2.68K ﹤0.01% 1952
2020
Q4 		$13K Sell
2,511
-36
-1% -$218 ﹤0.01% 1968
2020
Q3 		$14K Hold
2,547
– – ﹤0.01% 1790
2020
Q2 		$17K Hold
2,547
– – ﹤0.01% 1625
2020
Q1 		$12K Sell
2,547
-635
-20% -$3.9K ﹤0.01% 1712
2019
Q4 		$27K Buy
3,182
+53
+2% +$386 ﹤0.01% 1501
2019
Q3 		$21K Buy
+3,129
New +$23.2K ﹤0.01% 1743
2019
Q1 		$6K Sell
600
-2,558
-81% -$21.4K ﹤0.01% 1811
2018
Q4 		$24K Buy
3,158
+2,558
+426% +$30.6K ﹤0.01% 2025
2018
Q3 		$10K Sell
600
-4,000
-87% -$47.6K ﹤0.01% 2868
2018
Q2 		$44K Buy
+4,600
New +$30.6K ﹤0.01% 2006
2016
Q2 		– Sell
-600
Closed -$6K – 4085
2016
Q1 		$6K Buy
+600
New +$1.21K ﹤0.01% 1805

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

IFP Advisors's VKTX Position: Q2 2026 in Review

IFP Advisors increased its Viking Therapeutics (VKTX) stake by 1.7% in Q2 2026, buying an estimated $33.7K and bringing the position to 61,616 shares worth $2.4M. The position accounts for 0.04% of the portfolio, ranked #431.

IFP Advisors first reported a position in VKTX in Q1 2016 and has held it in 27 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • IFP Advisors held 61,616 shares of Viking Therapeutics worth $2.4M as of Q2 2026.
  • IFP Advisors bought 1,043 Viking Therapeutics shares in Q2 2026, an estimated $33.7K.
  • Viking Therapeutics made up 0.04% of IFP Advisors's portfolio in Q2 2026, its #431 holding.
  • IFP Advisors first reported a position in Viking Therapeutics in Q1 2016 and has held it in 27 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.